Tower Research Capital LLC (Trc) Acrivon Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $5.8 Billion
  • Q2 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,779 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,779
Previous 817 362.55%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
N/A
2,962 Added 362.55%
3,779 $0
Q1 2024

May 15, 2024
SELL
N/A
-1,201 Reduced 59.51%
817 $0
Q4 2023

Feb 13, 2024
BUY
N/A
763 Added 60.8%
2,018 $0
Q3 2023

Nov 14, 2023
BUY
N/A
523 Added 71.45%
1,255 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-360 Reduced 32.97%
732 $0
Q1 2023

May 09, 2023
BUY
N/A
933 Added 586.79%
1,092 $14,000
Q4 2022

Feb 10, 2023
BUY
N/A
159 New
159 $2,000

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.7M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email